All Roll Calls
Yes: 172 • No: 0
Sponsored By: Turner-Ford
Signed by Governor
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
7 provisions identified: 5 benefits, 0 costs, 2 mixed.
Beginning July 1, 2026, Mississippi treats many fentanyl-like substances as Schedule I drugs. The law defines fentanyl-related drugs by their chemical structure. Any drug that fits the definition counts as Schedule I unless it is excepted or moved to another schedule. Police and prosecutors can charge these as Schedule I offenses.
Beginning July 1, 2026, the law lists more opium derivatives, such as heroin and desomorphine, in Schedule I. Their salts, isomers, and salts of isomers are also covered. These drugs count as Schedule I unless excepted or placed in another schedule.
The law takes effect July 1, 2026. On that date, all Schedule I changes in this act apply statewide.
Beginning July 1, 2026, many stimulants and synthetic cathinones are Schedule I. The law defines synthetic cathinones by their chemical structure and lists examples like dipentylone, 4-CMC, alpha-PiHP, 3-MMC, and ethylphenidate. These substances count as Schedule I unless excepted or listed elsewhere.
Beginning July 1, 2026, synthetic cannabinoids are Schedule I. Any product with any amount of the listed synthetic cannabinoids is covered. The rule applies unless a substance is excepted or put into another schedule.
Beginning July 1, 2026, certain depressants, including GHB (and sodium oxybate), clonazolam, flualprazolam, flubromazolam, and others, are Schedule I. These drugs are treated as Schedule I unless they are excepted or placed in another schedule. This gives law enforcement Schedule I authority over these depressants.
Beginning July 1, 2026, many hallucinogens and tetrahydrocannabinols are Schedule I in Mississippi. The law keeps exemptions for hemp regulated under state law and FDA-approved CBD drugs. It also exempts processed cannabis stalks, sterilized seeds in animal feed, some THC industrial materials, and personal-care products with seed oil that do not let THC enter the body. FDA-approved ingestible hemp products remain exempt, and this does not cover dronabinol or nabilone. If an exemption does not apply, the item is treated as Schedule I.
Turner-Ford
Affiliation unavailable
There are no cosponsors for this bill.
All Roll Calls
Yes: 172 • No: 0
House vote • 3/4/2026
Passed
Yes: 120 • No: 0
Senate vote • 2/5/2026
Passed
Yes: 52 • No: 0
Approved by Governor
Enrolled Bill Signed
Enrolled Bill Signed
Returned For Enrolling
Passed
Title Suff Do Pass
Referred To Drug Policy
Transmitted To House
Immediate Release
Passed
Title Suff Do Pass
Referred To Drug Policy
As Introduced
As Passed
Enrolled
SB 3110 — Tax credits; authorize for contributions by certain taxpayers to certain hospitals.
SB 3051 — Appropriation; Finance and Administration, Department of.
SB 2917 — Budget; provide for various transfers of funds, and create various special funds.
SB 3072 — Appropriation; Mental Health, Department of.
SB 3053 — Appropriation; IHL - General support.
SB 3105 — Appropriation; additional to certain state agencies and boards for FY2026 and FY2027.